title: CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
authors.affiliation: Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Furukawa
authors.forename: K
authors.initials: K
authors.lastname: Nishi
authors.forename: T
authors.initials: T
authors.lastname: Kondo
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuno
authors.forename: H
authors.initials: H
authors.lastname: Narabayashi
mesh_terms: D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid*; D004305:Dose-Response Relationship, Drug; D004421:Dystonia / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D010302:Parkinson Disease, Secondary / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D012307:Risk Factors; D013787:Thalamic Nuclei / Q000187:drug effects / Q000601:surgery
chemical_list: D001708:Biopterins; D007980:Levodopa; D019798:Neopterin